Dr. Tina McKeon will be speaking about ongoing debates in the US and abroad about the implications of vaccine patenting for medical innovation and equitable access to healthcare, with a particular focus on waivers or march-in rights for COVID-19 vaccines.
Dr. McKeon is a patent attorney based in Atlanta, Georgia. After receiving her Ph.D. in Anatomy (Neuroscience) from the University of Alabama at Birmingham, she went on to graduate from Emory University School of Law. Dr. McKeon’s patent practice focuses on the life sciences, pharmaceutical, and biotechnology fields. Her biotechnology experience includes neuroscience, immunology, therapeutic antibodies, oncolytic virus therapy, stem cell technology, and recombinant technologies in a variety of areas including food and food supplements. Dr. McKeon has worked extensively with medical technology and pharmaceuticals, including cardiac technology, imaging, and diagnostics as well as small molecule pharmaceuticals and biologics.